Headache is one of the most searched side effects of GLP-1 treatment, and one of the least explained. Most articles list it and move on. The useful part is why it happens, because the cause usually points straight at the fix.
Quick Answer
As of September 26, 2026, headache is a commonly reported side effect of semaglutide, and people on either medication describe it most often early in treatment and after a dose change. The medication may not be the whole story: treatment changes how much you drink, how much you eat, your caffeine habits and your sleep, and each of those can cause headaches on its own.
Why GLP-1 Treatment Produces Headaches
Four ordinary contributors are worth checking first, and they overlap.
You are drinking less than you think. When appetite drops, fluid intake can fall with it, quietly, without any decision to drink less. Headache is a recognised sign of mild to moderate dehydration, which makes fluid intake the first thing to check in the early weeks of treatment. If nausea or vomiting is also in the picture, the deficit builds faster.
You are eating less, and further apart. Long gaps between meals and low blood sugar are classic triggers. A person who used to eat every four hours and now eats twice a day has changed something the body was used to, whatever the scale says about it.
Your caffeine habit changed without you noticing. Coffee is often the first thing to go when food stops appealing, and a sudden drop in caffeine produces a textbook withdrawal headache, usually within a day or two. This one is easy to miss because the change was not deliberate.
You are sleeping differently. Early nausea, unfamiliar fullness and a body adjusting to a new medication all disturb sleep, and poor sleep is its own headache trigger. Our article on fatigue during treatment covers the sleep side in more detail.
Headache is listed among the most common adverse reactions in the prescribing information for approved semaglutide products. The prescribing information for approved tirzepatide products lists it only as a possible sign of low blood sugar, not among the most common adverse reactions. Compounded medications are not FDA-approved as final products and have not been evaluated by the FDA for safety, effectiveness, or quality.
The Pattern Most People Describe
Not a rule, and not a promise about you, but the shape that recurs:
| When | What people describe |
|---|---|
| Early in treatment | Dull, pressing headache, often with early nausea |
| Days after a dose increase | The same pattern returning briefly |
| Settled on a steady dose | Usually fades as the body adjusts |
| Months in, new headache | Worth attention rather than assumption |
That last row matters most. A headache appearing months into steady treatment is not automatically the medication, and treating it as expected can delay finding what it actually is.
What Helps Day to Day
None of this is exciting, which is why it gets skipped.
Drink more than feels necessary. You will not feel thirsty in proportion to what you need, because the signal that used to tell you is quieter. Keeping water visible and drinking on a schedule works better than waiting to want it.
Eat on a rhythm, not on appetite. Small, regular, protein-forward meals hold blood sugar steadier than two large gaps. Our guide to protein targets during treatment covers the practical side of eating when you are not hungry.
Keep caffeine steady. If coffee has quietly dropped out, that alone can explain the headache. Change it gradually rather than abruptly, in either direction.
Protect sleep. Same hours, dark room, and an honest look at whether evening nausea is what is waking you.
Ask before you medicate. Which pain reliever suits you depends on your kidney function, your stomach, your blood pressure and everything else you take. That is a question for your pharmacist or prescriber, and it is a short conversation.
When a Headache Is Not Routine
Some headaches are not a side effect to manage. Call 911 or go to the nearest emergency department for a headache that:
- comes on suddenly and severely, the worst you have experienced,
- arrives with vision changes, confusion, weakness or numbness on one side, or difficulty speaking,
- comes with a stiff neck and fever, or with a seizure.
Contact your prescriber, without waiting, if a headache:
- keeps getting worse instead of easing,
- has not settled after a couple of weeks,
- wakes you from sleep,
- arrives with severe abdominal pain, or with vomiting you cannot keep fluids down through,
- comes with shakiness, sweating and difficulty concentrating, which together can point at low blood sugar. That matters especially for anyone also taking insulin or a sulfonylurea, where the prescriber may want to look at the other medication rather than the GLP-1.
Telehealth is not for emergencies. The list above is the line between the two.
Semaglutide Versus Tirzepatide
Headache is listed among the most common adverse reactions for approved semaglutide products; for approved tirzepatide products the prescribing information mentions it only as a possible sign of low blood sugar. The everyday contributors are the same, and so is the practical approach. What differs between people is far larger than what differs between the two medications, which is why the decision about which one, and at what dose, belongs to the physician who reviewed your history rather than to an article.
What Not to Do
Do not change your dose to chase a headache. Dose decisions belong to your prescriber, who is weighing your history, your other medications and your response, and a change made at home removes them from a decision they are accountable for. Tell them what you are experiencing instead: that is the information they need, and it is the fastest route to a plan that fits.
What the primary sources say
- DailyMed, WEGOVY (semaglutide) prescribing information, Medication Guide (accessed September 26, 2026): "The most common side effects of WEGOVY in adults or children aged 12 years and older may include: • nausea • stomach (abdomen) pain • dizziness • gas • diarrhea • changes in skin sensations • feeling bloated • vomiting • headache"
- DailyMed, ZEPBOUND (tirzepatide) prescribing information, Medication Guide (accessed September 26, 2026): "Signs and symptoms of low blood sugar may include: dizziness or light-headedness sweating confusion or drowsiness headache"
- MedlinePlus, Caffeine (accessed September 26, 2026): "If you have been consuming caffeine on a regular basis and then suddenly stop, you may have caffeine withdrawal. Symptoms can include: Headaches"
- MedlinePlus Medical Encyclopedia, Dehydration (accessed September 26, 2026): "Signs of mild to moderate dehydration include: Thirst Dry or sticky mouth Not urinating much Darker yellow urine Dry, cool skin Headache"
- MedlinePlus Drug Information, Semaglutide Injection (accessed September 26, 2026): "Signs and symptoms of low blood sugar may include dizziness or lightheadedness, irritability, sweating, hunger, drowsiness, shakiness, weakness, headache, slurred speech, blurred vision, fast heart rate and feeling jittery."
Frequently Asked Questions
Does semaglutide cause headaches?
Headache is listed among the reported adverse reactions in the prescribing information for approved semaglutide products, and patients commonly describe it in the first weeks of treatment and in the days after a dose increase. In most accounts it is a dull, pressing headache rather than a severe one, and it tends to ease as the body adjusts. The medication may not be the whole story: treatment changes how much you eat and drink, and dehydration, longer gaps between meals, and altered caffeine habits are all familiar headache triggers on their own.
How long do GLP-1 headaches last?
There is no fixed number, and anyone who gives you one is guessing. The pattern people describe most often is a few days around a change, whether that is starting treatment or moving to a higher dose, easing as the body settles. A headache that is getting worse rather than better, or that has not settled after a couple of weeks, is a reason to speak with your prescriber rather than to wait it out.
What helps a headache on semaglutide?
The measures that help most are unglamorous: drink more than feels necessary, because appetite loss quietly reduces fluid intake too; keep eating regularly even when you are not hungry, since long gaps and low blood sugar are classic triggers; keep caffeine steady rather than cutting it suddenly, because caffeine withdrawal produces a textbook headache; and protect sleep. Before taking any pain reliever, ask your pharmacist or prescriber which one suits you and your other medications: that answer depends on your history, not on general advice.
Can a headache be a sign of low blood sugar on a GLP-1?
It can. Headache, shakiness, sweating, irritability and difficulty concentrating are recognised symptoms of low blood sugar. On its own a GLP-1 rarely drives blood sugar that low, but the risk rises for people also taking insulin or a sulfonylurea. Anyone in that group should raise it with their prescriber, who may want to review the other medication rather than the GLP-1.
Which headaches mean I should call someone?
A headache that comes on suddenly and severely, the worst you have had, or one that arrives with vision changes, confusion, weakness or numbness on one side, difficulty speaking, a stiff neck with fever, or a seizure, needs emergency care rather than a message. Call 911 or go to the nearest emergency department. Separately, contact your prescriber if a headache keeps getting worse, does not settle, wakes you from sleep, or arrives alongside severe abdominal pain or vomiting you cannot keep fluids down through.
Do headaches happen with tirzepatide too?
They can. The prescribing information for approved tirzepatide products does not list headache among the most common adverse reactions; it appears there only as a possible sign of low blood sugar. The everyday contributors that can cause a headache during treatment are the same on either medication: reduced intake, dehydration, altered caffeine habits, and disturbed sleep. The practical approach does not differ between the two medications, and any decision about dose belongs to the prescriber in either case.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.DailyMed - WEGOVY- semaglutide injection, solution WEGOVY- semaglutide tablet · U.S. National Library of Medicine, DailyMed (Novo Nordisk prescribing information, SPL version 19, published Jun 30, 2026) · accessed
- 2.DailyMed - ZEPBOUND- tirzepatide injection, solution ZEPBOUND KWIKPEN- tirzepatide injection, solution · U.S. National Library of Medicine, DailyMed (Eli Lilly prescribing information, SPL version 40, published Sep 02, 2026) · accessed
- 3.Compounding and the FDA: Questions and Answers · U.S. Food and Drug Administration · accessed
- 4.Low blood sugar: MedlinePlus Medical Encyclopedia · MedlinePlus, U.S. National Library of Medicine · accessed
- 5.A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features (Juliano LM, Griffiths RR. Psychopharmacology. 2004;176(1):1-29. PMID 15448977) · PubMed, National Library of Medicine · accessed
- 6.Headache: MedlinePlus Medical Encyclopedia · MedlinePlus, U.S. National Library of Medicine · accessed
- 7.Dehydration: MedlinePlus Medical Encyclopedia · MedlinePlus, U.S. National Library of Medicine · accessed
- 8.Caffeine: MedlinePlus · MedlinePlus, U.S. National Library of Medicine · accessed
- 9.Semaglutide Injection: MedlinePlus Drug Information · MedlinePlus, U.S. National Library of Medicine · accessed
Telehealth prescribing rules differ by state. Read the state-by-state guide.
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them